Clinical Trial Update: Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II single-arm study evaluating mFOLFOX6 with Bevacizumab and Atezolizumab in advanced biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• MFOLFOX6

Snippet

Sponsor: University Hospital, Essen | Conditions: Biliary Tract Cancer | Phase 1, Phase 2 | Status: COMPLETED